Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Ophthalmology. 2015 May 9;122(7):1471–1479. doi: 10.1016/j.ophtha.2015.04.007

Table 1.

Definition of Cataract and Number of Participants and Eyes in Analyses

A. Definition of controls and cataract types evaluated in the Age-Related Eye Disease Study (AREDS)
Cataract type Mild Moderate Controls
Nuclear AREDS nuclear grade >2 and ≤4 AREDS nuclear grade ≥4 AREDS nuclear grade ≤2
Cortical Cortical >0% and <10% Cortical ≥10% Cortical = 0%
Posterior Subcapsular (PSC) PSC >0% and <5% PSC ≥5% PSC = 0%
1B. Numbers of participants and eyes included in the prevalence analyses of the lutein/zeaxanthin and vitamin B and cataracts analyses
Nuclear Cortical
N participants N eyes N (%) eyes with event N eyes N participants N (%) eyes with event
Mild 2939 5582 2279 (40.8) 2788 5296 3294 (62.2)
Moderate 2358 3840 537 (14.0) 1852 2618 616 (23.5)
1C. Numbers of participants and eyes included in the incidence analyses of the lutein/zeaxanthin and vitamin B and cataracts analyses
Centrum=No Centrum=Yes
Opacity N participants N eyes N (%) eyes with event N eyes N participants N (%) eyes with event
Mild Nuclear 639 1045 734 (70.2) 1190 1963 1279 (65.2)
Cortical 470 658 312 (47.4) 903 1245 619 (49.7)
PSC 939 1727 185 (10.7) 1807 3315 347 (10.5)
Moderate Nuclear 505 674 326 (48.4) 966 1354 617 (45.6)
Cortical 583 825 293 (35.5) 1132 1597 590 (36.9)
PSC 951 1716 161 (9.4) 1842 3326 313 (9.4)
Cat surgery 1043 2047 558 (27.3) 2025 3985 1009 (25.3)